Non-alcoholic Fatty Liver and Vitamin D Levels in Extremely Obese Individuals: A Case–Control Study

Mohamed Sayed; Ebthal Mahmoud Abozeid; Hoda M. Amin; Naglaa M. Elsayed; Yasser H. Nassar; Hend A. Elsheimy

doi:10.3889/oamjms.2021.5976

Authors

Mohamed Sayed Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt
Ebthal Mahmoud Abozeid Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt https://orcid.org/0000-0002-3608-5179
Hoda M. Amin Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt
Naglaa M. Elsayed Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt
Yasser H. Nassar Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Giza, Egypt
Hend A. Elsheimy Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt https://orcid.org/0000-0001-8790-9804

DOI:

https://doi.org/10.3889/oamjms.2021.5976

Keywords:

Non-alcoholic fatty liver disease, Vitamin D, Extreme obesity

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is currently one of the most prevalent liver diseases. NAFLD is exemplified by the deposition of fat in the liver, in the absence of other etiologies. The spectrum of histological features in NAFLD ranges from macro-vesicular steatosis and nonalcoholic steatohepatitis, and it can eventually end in fibrosis, cirrhosis, or hepatocellular carcinoma. Vitamin D deficiency (VDD) is the most common micronutrient deficiency worldwide. Obese subjects are more prone to VDD, particularly those with liver disease. Non-classic functions of Vitamin D may be involved in the metabolic pathways beyond NAFLD development and progression.

AIM: The aim of the study was to evaluate the relationship between NAFLD and Vitamin D levels in extreme obese subjects, and the correlation between Vitamin D levels and NAFLD severity.

MATERIALS AND METHODS: The study included 80 Egyptian subjects of both sexes, divided into two groups: 50 patients with Stage III obesity (defined as body mass index [BMI] ≥40 kg/m²) and NAFLD, their age ranging from 20 to <60 years, and 30 age- and sex-matched healthy volunteers as control subjects. All patients were recruited from nutrition outpatient clinic at endocrinology unit, Cairo University Hospitals during the period from January 2019 to June 2019. Diagnosis of NAFLD was done by ultrasonography and laboratory evaluation included Vitamin D level. Nutritional evaluation included BMI, waist circumference, and weight.

RESULTS: Vitamin D was significantly lower in the NAFLD group versus healthy controls: About 34%, deficient, 32% insufficient, and 34% sufficient in NAFLD group versus 23.3% insufficient, and 76.7% sufficient only in control, p ˂ 0.001. The severity of NAFLD, as graded by ultrasonography, was positively correlated with BMI and inversely correlated with Vit D levels, p = 0.001 and 0.024, respectively. Multivariate linear regression proved that both BMI and Vit D were independent predictors for NAFLD progression, BMI in a positive manner and Vit D in a negative manner. A cutoff Vit D level of 27.75 had 64% sensitivity and 90% specificity in NAFLD detection, area under the curve was 0.821.

CONCLUSION: Vitamin D is significantly lower in the NAFLD group versus healthy controls in this cohort. VDD and BMI were associated with increased NAFLD severity. VDD was found to be an independent predictor of NAFLD progression. Vitamin D supplementation may be added to lifestyle modifications to prevent NAFLD occurrence in obese subjects.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Chalasani N, Younossi ZM, Lavine JE, Diehl AM, Brunt EM, Cusi K. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatology. 2012;55(6):20. https://doi.org/10.1002/hep.25762 PMid:22488764 DOI: https://doi.org/10.1002/hep.25762

Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59(3):1174-97. https://doi.org/10.1002/hep.26717 PMid:24002776 DOI: https://doi.org/10.1002/hep.26717

Vernon G, Baranova A, Younossi ZM. Systematic Review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274-85. https://doi.org/10.1111/j.1365-2036.2011.04724.x PMid:21623852 DOI: https://doi.org/10.1111/j.1365-2036.2011.04724.x

Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol. 2017;9(16):715-32. https://doi.org/10.4254/wjh.v9.i16.715 PMid:28652891 DOI: https://doi.org/10.4254/wjh.v9.i16.715

McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis. 2011;12(5):333-40. PMid:21091931 DOI: https://doi.org/10.1111/j.1751-2980.2010.00469.x

Nakahara T, Hyogo H, Yoneda M, Sumida Y, Eguchi Y, Fujii H, et al. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol. 2014;49(11):1477-84. https://doi.org/10.1007/s00535-013-0911-1 PMid:24277052 DOI: https://doi.org/10.1007/s00535-013-0911-1

Wacker M, Holiack MF. Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5(1):111-48. https://doi.org/10.3390/nu5010111 PMid:23306192 DOI: https://doi.org/10.3390/nu5010111

Entrenas AO, Tubio DL, Navarroet FL, Carvajal FM, Osinaga JA. Relationship between Vitamin D deficiency and the components of metabolic syndrome in patients with morbid obesity, before and 1 year after laparoscopic roux-en-Y gastric bypass or sleeve gastrectomy. Obesity Surg. 2017;27(5):1222-8. https://doi.org/10.1007/s11695-016-2445-0 PMid:27864670 DOI: https://doi.org/10.1007/s11695-016-2445-0

Kwok RM, Torres DM, Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association? Hepatology. 2013;58(3):1166-74. https://doi.org/10.1002/hep.26390 PMid:23504808 DOI: https://doi.org/10.1002/hep.26390

Han S, Li T, Ellis E, Strom S, Chiang JY. A novel bile acid-activated Vitamin D receptor signaling in human hepatocytes. Mol Endocrinol. 2010;24(6):1151-64. https://doi.org/10.1210/me.2009-0482 PMid:20371703 DOI: https://doi.org/10.1210/me.2009-0482

Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, Angelico F, et al. Liver Vitamin D receptor, CYP2R1, and CYP27A1 expression: Relationship with liver histology and Vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology. 2012;56(6):2180-7. https://doi.org/10.1002/hep.25930 PMid:22753133 DOI: https://doi.org/10.1002/hep.25930

Norman AW. From Vitamin D to hormone D: Fundamentals of the Vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88(2):491S-9. https://doi.org/10.1093/ajcn/88.2.491s PMid:18689389 DOI: https://doi.org/10.1093/ajcn/88.2.491S

World Health Organization. World Health Statistics 2011. Geneva: World Health Organization; 2014. [Last accessed on 2020 June 10]. Available from: http://www.who.int/healthinfo/statistics/en/index.html.

Lequin RM. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem. 2005;51(12):2415-8. https://doi.org/10.1373/clinchem.2005.051532 PMid:16179424 DOI: https://doi.org/10.1373/clinchem.2005.051532

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of Vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. https://doi.org/10.1210/jc.2011-0385 PMid:21646368 DOI: https://doi.org/10.1210/jc.2011-0385

Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745-50. https://doi.org/10.1053/gast.2002.35354 PMid:12198701 DOI: https://doi.org/10.1053/gast.2002.35354

Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708-15. https://doi.org/10.1111/j.1572-0241.2007.01526.x PMid:17894848 DOI: https://doi.org/10.1111/j.1572-0241.2007.01526.x

Benoit SC, Hunter TD, Francis DM, De La Cruz-Munoz N. Use of bariatric outcomes longitudinal database (BOLD) to study variability in patient success after bariatric surgery. Obes Surg. 2014;24(6):936-43. https://doi.org/10.1007/s11695-014-1197-y PMid:24570089 DOI: https://doi.org/10.1007/s11695-014-1197-y

Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: Vitamin D and non-alcoholic fatty liver disease. Alimentary Pharmacol Therapeut. 2013;38(3):246-54. https://doi.org/10.1111/apt.12377 PMid:23786213 DOI: https://doi.org/10.1111/apt.12377

Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24. https://doi.org/10.1016/j.numecd.2006.04.002 PMid:16928437 DOI: https://doi.org/10.1016/j.numecd.2006.04.002

Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34(6):e118-27. https://doi.org/10.1111/liv.12312 PMid:24118743 DOI: https://doi.org/10.1111/liv.12312

Patel YA, Henao R, Moylan CA, Guy CD, Piercy DL, Diehl AM, et al. Vitamin D is not associated with severity in NAFLD: Results of a paired clinical and gene expression profile analysis. Am J Gastroenterol. 2016;111(11):1591-8. https://doi.org/10.1038/ajg.2016.406 PMid:27644736 DOI: https://doi.org/10.1038/ajg.2016.406

Paula FV, Leandra R, de Paula Francisco A, Martinelli AD. Low Vitamin D level is not associated with severity of non-alcoholic fatty liver disease in morbidly obese patients. J Hepatol. 2017;66:S157. https://doi.org/10.1016/s0168-8278(17)30588-3 DOI: https://doi.org/10.1016/S0168-8278(17)30588-3

Kasapoglu B, Turkay C, Yalcin KS, Carlioglu A, Sozen M, Koktener A. Low Vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults. Clin Med. 2013;13(6):576-9. https://doi.org/10.7861/clinmedicine.13-6-576 PMid:24298105 DOI: https://doi.org/10.7861/clinmedicine.13-6-576

Kim HS, Rotundo L, Kothari N, Kim SH, Pyrsopoulos N. Vitamin D is associated with severity and mortality of non-alcoholic fatty liver disease: A US population-based study. J Clin Transl Hepatol. 2017;5(3):185-92. https://doi.org/10.14218/jcth.2017.00025 PMid:28936398 DOI: https://doi.org/10.14218/JCTH.2017.00025

Gad AI, Elmedames MR, Abdelhai AR, Marei AM. The association between Vitamin D status and non-alcoholic fatty liver disease in adults: A hospital-based study. Egypt Liver J. 2020;10:25. https://doi.org/10.1186/s43066-020-00033-z DOI: https://doi.org/10.1186/s43066-020-00033-z

Mohamed AA, Mahmoud S, Ahmed R, Ahmed R, Fadl H, Atallah MA, et al. Vitamin D is it a key in Egyptian NAFLD pathogenesis? J Gastroenterol Hepatol. 2015;4:1605-9. https://doi.org/10.17554/j.issn.2224-3992.2015.04.522 DOI: https://doi.org/10.17554/j.issn.2224-3992.2015.04.522